Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Inhibrx Biosciences, Inc
IGM Biosciences, Inc.
Taiho Pharmaceutical Co., Ltd.
TG Therapeutics, Inc.
Mayo Clinic
Valerio Therapeutics